ABEO - Abeona Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5183.87M
Enterprise Value 3129.09M
Trailing P/E N/A
Forward P/E 1-2.44
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)74.53
Price/Book (mrq)1.52
Enterprise Value/Revenue 352.33
Enterprise Value/EBITDA 6-2.06

Trading Information

Stock Price History

Beta (3Y Monthly) 1.06
52-Week Change 3-72.27%
S&P500 52-Week Change 36.70%
52 Week High 315.6500
52 Week Low 33.7300
50-Day Moving Average 34.8109
200-Day Moving Average 36.6820

Share Statistics

Avg Vol (3 month) 3599.9k
Avg Vol (10 day) 3563.38k
Shares Outstanding 548.09M
Float 28.55M
% Held by Insiders 133.45%
% Held by Institutions 168.66%
Shares Short (Jun 28, 2019) 46.61M
Short Ratio (Jun 28, 2019) 48.04
Short % of Float (Jun 28, 2019) 425.17%
Short % of Shares Outstanding (Jun 28, 2019) 413.45%
Shares Short (prior month May 31, 2019) 47.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Oct 24, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,697.08%

Management Effectiveness

Return on Assets (ttm)-24.33%
Return on Equity (ttm)-45.09%

Income Statement

Revenue (ttm)2.47M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-35.7M
EBITDA -62.69M
Net Income Avi to Common (ttm)-64.7M
Diluted EPS (ttm)-1.3550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.31M
Total Cash Per Share (mrq)1.39
Total Debt (mrq)8.62M
Total Debt/Equity (mrq)7.32
Current Ratio (mrq)3.35
Book Value Per Share (mrq)2.46

Cash Flow Statement

Operating Cash Flow (ttm)-50.11M
Levered Free Cash Flow (ttm)-33.88M